U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07049653) titled 'Anifrolumab Pregnancy Study' on May 23.
Brief Summary: This is a non-interventional multi-database post-authorisation study to assess pregnancy-related safety data from women with SLE exposed to Anifrolumab.
Study Start Date: Jan. 31, 2026
Study Type: OBSERVATIONAL
Condition:
Systemic Lupus Erythematosus
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....